What is the problem they offered 2 cents per share and the shareholders had the opportunity to take the offer which was 54% above the share price at that time.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025